Experimental MYC Blocker OMO-103 Drew Cancer-Fighting T Cells Into KRAS-Mutant Lung Tumor Samples in Lab Tests
Laboratory and mouse studies suggest OMO-103 may help immune cells attack KRAS-mutant lung tumors, but the early findings have not yet been confirmed in patients.
Medical Daily ·